Patching it together: epicutaneous vaccination with heat-labile Escherichia coli toxin against birch pollen allergy
Crossing the threshold: can outcome data from food challenges be used to predict risk of anaphylaxis in the community?
Allergen-specific immunotherapy: is it vaccination against toxins after all?
Nonallergic rhinitis and lower airway disease
Immunotherapy in allergic rhinitis and lower airway outcomes
Conjunctival allergen provocation test: guidelines for daily practice
Increased microRNA-323-3p in IL-22/IL-17-producing T cells and asthma: a role in the regulation of the TGF-β pathway and IL-22 production
Ontogeny of human IgE-expressing B cells and plasma cells
A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients
Proteome analysis identifies L1CAM/CD171 and DPP4/CD26 as novel markers of human skin mast cells
Application of recombinant antigen 5 allergens from seven allergy-relevant Hymenoptera species in diagnostics
Environmental and mucosal microbiota and their role in childhood asthma
Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)-11 revision
Protein phosphatase 5 mediates corticosteroid insensitivity in airway smooth muscle in patients with severe asthma
Asthma–COPD overlap syndrome (ACOS) vs ‘pure’ COPD: a distinct phenotype?
Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review
Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination